Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease

Renal Failure

Volumn 33, Issue 9, 2011, Pages 866-874

  Karsli Ceppioǧlu, Seher ^a   Yurdun, Turkan ^a   Canbakan, Mustafa ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Chronic kidney disease; End stage renal disease; Genetic polymorphism; Klotho gene; Matrix Gla protein gene; Oxidative DNA damage

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CALCIUM BINDING PROTEIN; COPPER; KLOTHO PROTEIN; PROTEIN MGP; UNCLASSIFIED DRUG; ZINC;

ADULT; ALLELE; ARTICLE; CHRONIC KIDNEY DISEASE; COMET ASSAY; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; DEOXYGUANOSINE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENOTYPE; GLUCURONIDASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; REFERENCE VALUES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 80053508957     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.605534     Document Type: Article

References (57)

1. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int. 2001;60:472-479 (Pubitemid 32680895)
2. Serdengeçti K, Suleymanlar G, Alt?parmak MR, Seyahi N. Registry of Nephrology, Dialysis and Transplantation in Turkey, Registry 2008. Istanbul: Turkish Society of Nephrology; 2009
3. Kanbay M, Goldsmith D, Akcay A, Covic A. Phosphate - The silent stealthy cardiorenal culprit in all stages of chronic kidney disease: A systematic review. Blood Purif. 2009;27:220-230
4. Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16:529-538. (Pubitemid 41725151)
5. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58:353-362 (Pubitemid 30429882)
6. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62:1524-1538 (Pubitemid 35286260)
7. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: How do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008;3: 505-521
8. Goldsmith D, Ritz E, Covic A. Vascular calcification: A stiff challenge for the nephrologist: Does preventing bone disease cause arterial disease? Kidney Int. 2004;66:1315-1333 (Pubitemid 39298364)
9. Martola L, Barany P, Stenvinkel P. Why do dialysis patients develop a heart of stone and bone of china? Blood Purif . 2005;23:203-210 (Pubitemid 40874899)
10. Nordfors L, Lindholm B, Stenvinkel P. End-stage renal disease - Not an equal opportunity disease: The role of genetic polymorphisms. J Intern Med. 2005;258:1-12 (Pubitemid 40904927)
11. Schafer C, Heiss A, Schwarz A, et al. The serum protein 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112:357-366 (Pubitemid 38063764)
12. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerindeficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998;12:1260-1268 (Pubitemid 28213402)
13. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386:78-81 (Pubitemid 27130923)
14. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, Williamson MK. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gammacarboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem. 2002;277:3926-3934 (Pubitemid 34968645)
15. Munroe PB, Olgunturk RO, Fryns JP, et al. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet. 1999;21:142-144 (Pubitemid 29036302)
16. Meier M, Weng LP, Alexandrakis E, Rüschoff J, Goeckenjan G. Tracheobronchial stenosis in Keutel syndrome. Eur Respir J. 2001;17:566-569 (Pubitemid 32600627)
17. Farzaneh-Far A, Davies JD, Braam LA, et al. A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J Biol Chem. 2001;276:32466-32473
18. Herrmann SM, Whatling C, Brand E, et al. Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol. 2000;20:2386-2393
19. Brancaccio D, Biondi ML, Gallieni M, et al. Matrix GLA protein gene polymorphisms: Clinical correlates and cardiovascular mortality in chronic kidney disease patients. Am J Nephrol. 2005;25:548-552 (Pubitemid 41816049)
20. Kuro-o M. Klotho. Pflugers Arch. 2010;459:333-343
21. Ito S, Fujimori T, Furuya A, Satoh J, Nabeshima Y, Nabeshima Y. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. J Clin Invest. 2005;115:2202-2208 (Pubitemid 41134162)
22. Takeshita K, Fujimori T, Kurotaki Y, et al. Sinoatrial node dysfunction and early unexpected death of mice with a defect of Klotho gene expression. Circulation. 2004;109:1776-1782 (Pubitemid 38500681)
23. Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444:770-774 (Pubitemid 44949607)
24. Koh N, Fujimori T, Nishiguchi S, et al. Severely reduced production of Klotho in human chronic renal failure kidney. Biochem Biophys Res Commun. 2001;280:1015-1020 (Pubitemid 32924441)
25. Kurosu H, Yamamoto M, Clark JD, et al. Suppression of aging in mice by the hormone Klotho. Science 2005;309: 1829-1833 (Pubitemid 41325087)
26. Arking DE, Krebsova A, Macek M, Sr., et al. Association of human aging with a functional variant of klotho. Proc Natl Acad Sci USA. 2002;99:856-861 (Pubitemid 34106600)
27. Arking DE, Becker DM, Yanek LR, et al. KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am J Hum Genet. 2003;72:1154-1161 (Pubitemid 36530003)
28. Lim PS, Chang YM, Thien LM, et al. 8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients. Blood Purif. 2002;20:537-542
29. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62: 1524-1538 (Pubitemid 35286260)
30. Uhlig K, Berns JS, Kestenbaum B, et al. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis. 2010;55: 773-799
31. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175:184-191
32. Collins AR. The comet assay. Principles, applications, and limitations. Methods Mol Biol. 2002;203:163-177
33. Toyokuni S, Tanaka T, Hattori Y, et al. Quantitative immunohistochemical determination of 8-hydroxy-28-deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest. 1997;76:365-374 (Pubitemid 27157344)
34. Yamada Y, Ando F, Niino N, Shimokata H. Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women. J Mol Med. 2005;83:50-57 (Pubitemid 40169496)
35. de Jong PE, van der Velde M, Gansevoort RT, Zoccali C. Screening for chronic kidney disease: Where does Europe go? Clin J Am Soc Nephrol. 2008;3:616-623
36. Zoccali C. Cardiorenal risk as a new frontier of nephrology: Research needs and areas for intervention. Nephrol Dial Transplant. 2002;17:50-54 (Pubitemid 35277066)
37. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18:1731-1740 (Pubitemid 37098542)
38. Proudfoot D, Shanahan CM. Molecular mechanisms mediating vascular calcification: Role of matrix Gla protein. Nephrology. 2006;11:455-461 (Pubitemid 44470096)
39. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004;95:560-567. (Pubitemid 39274370)
40. Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004;15: 2857-2867 (Pubitemid 41103395)
41. Farzaneh-Far A, Shanahan CM. Biology of vascular calcification in renal disease. Nephron Exp Nephrol. 2005;101: e134-e138
42. Crosier MD, Booth SL, Peter I, et al. Matrix Gla protein polymorphisms are associated with coronary artery calcification in men. J Nutr Sci Vitaminol (Tokyo). 2009;55:59-65
43. Kobayashi N, Kitazawa R, Maeda S, Schurgers L, Kitazawa S. T-138C polymorphism of matrix gla protein promoter alters its expression but is not directly associated with atherosclerotic vascular calcification. Kobe J Med Sci. 2004;50:69-81 (Pubitemid 41007604)
44. Schurgers LJ, Teunissen KJ, Knapen MH, et al. Characteristics and performance of an immunosorbent assay for human matrix Gla-protein. Clin Chim Acta. 2005;351:131-138 (Pubitemid 39563566)
45. Manghat P, Souleimanova I, Cheung J, et al. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD). Bone. 2011;48:1127-1132
46. Braam LA, Dissel P, Gijsbers BL, et al. Assay for human matrix gla protein in serum: Potential applications in the cardiovascular field. Arterioscler Thromb Vasc Biol. 2000;20:1257-1261 (Pubitemid 30262926)
47. Arking DE, Atzmon G, Arking A, Barzilai N, Dietz HC. Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res. 2005;96:412-418 (Pubitemid 40354534)
48. Kawano K, Ogata N, Chiano M, et al. Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J Bone Miner Res. 2002;17:1744-1751
49. Ogata N, Matsumura Y, Shiraki M, et al. Association of klotho gene polymorphism with bone density and spondylosis of the lumbar spine in postmenopausal women. Bone 2002;31: 37-42 (Pubitemid 34754423)
50. Yamamoto M, Clark JD, Pastor JV, et al. Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem. 2005;280:38029-38034 (Pubitemid 41642417)
51. Dounousi E, Papavasiliou E,Makedou A, et al. Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis. 2006;48:752-760 (Pubitemid 44740054)
52. Batista MN, Cuppari L, de Fátima Campos Pedrosa L, et al. Effect of end-stage renal disease and diabetes on zinc and copper status. Biol Trace Elem Res. 2006;112:1-12 (Pubitemid 44337201)
53. Bozalio?glu S, Ozkan Y, Turan M, Simsek B. Prevalence of zinc deficiency and immune response in short-term hemodialysis. J Trace Elem Med Biol. 2005;18:243-249
54. Navarro-Alarcon M, Reyes-Pérez A, Lopez-Garcia H, Palomares-Bayo M, Olalla-Herrera M, Lopez-Martinez MC. Longitudinal study of serum zinc and copper levels in hemodialysis patients and their relation to biochemical markers. Biol Trace Elem Res. 2006;113:209-222 (Pubitemid 46035377)
55. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339:1-9 (Pubitemid 37542453)
56. Domenici FA, Vannucchi MT, Jordão Jr. AA, Meirelles MS, Vannucchi H. DNA oxidative damage in patients with dialysis treatment. Ren Fail. 2005;27:689-694 (Pubitemid 41748120)
57. Stopper H, Boullay F, Heidland A, Vienken J, Bahner U. Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. Am J Kidney Dis. 2001;38:296-301